Evidence
Nat Commun. 2023 Aug 19;14(1):5053. doi: 10.1038/s41467-023-40681-4.
ABSTRACT
Brain exposure of systemically administered biotherapeutics is highly restricted by the blood-brain barrier (BBB). Here, we report the engineering and characterization of a BBB transport vehicle targeting the CD98 heavy chain (CD98hc or SLC3A2) of heterodimeric amino acid transporters (TVCD98hc). The pharmacokinetic and biodistribution properties of a CD98hc antibody transport vehicle (ATVCD98hc) are assessed in humanized CD98hc knock-in mice and cynomolgus monkeys. Compared to most existing BBB platforms targeting the transferrin receptor, peripherally administered ATVCD98hc demonstrates differentiated brain delivery with markedly slower and more prolonged kinetic properties. Specific biodistribution profiles within the brain parenchyma can be modulated by introducing Fc mutations on ATVCD98hc that impact FcγR engagement, changing the valency of CD98hc binding, and by altering the extent of target engagement with Fabs. Our study establishes TVCD98hc as a modular brain delivery platform with favorable kinetic, biodistribution, and safety properties distinct from previously reported BBB platforms.
PMID:37598178 | DOI:10.1038/s41467-023-40681-4
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
CD98hc is a target for brain delivery of biotherapeutics
🌐 90 Days
VR Related Evidence Matrix
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia
- In vitro study of the blood-brain barrier transport of bioactives from Mediterranean foods
- Blood-brain barrier disruption following brain injury: Implications for clinical practice
- Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review
- Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR delta activation
- Analysis of ischemic stroke-mediated effects on blood-brain barrier properties along the arteriovenous axis assessed by intravital two-photon imaging
- Alterations of the blood-brain barrier during aging
- Alcohol binge drinking induces downregulation of blood-brain barrier proteins in the rat frontal cortex -but not in the hippocampus- that is not prevented by OEA pretreatment
- C9ORF72 patient-derived endothelial cells drive blood-brain barrier disruption and contribute to neurotoxicity
- Specific nanoprobe design for MRI: Targeting laminin in the blood-brain barrier to follow alteration due to neuroinflammation
- Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases
- Engineered Wnt7a ligands rescue blood-brain barrier and cognitive deficits in a COVID-19 mouse model
- Inflammation-induced TRPV4 channels exacerbate blood-brain barrier dysfunction in multiple sclerosis
- Binary Nano-inhalant Formulation of Icariin Enhances Cognitive Function in Vascular Dementia via BDNF/TrkB Signaling and Anti-inflammatory Effects
- Neural and Onconeural Autoantibodies and Blood-Brain Barrier Disruption Markers in Patients Undergoing Radiotherapy for High-Grade Primary Brain Tumour
- Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma
- Feasibility of measuring blood-brain barrier permeability using ultra-short echo time radial magnetic resonance imaging
- Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii
- Blood-brain barrier breakdown and autoimmune cerebellar ataxia
- Neutrophil Targeting Platform Reduces Neutrophil Extracellular Traps for Improved Traumatic Brain Injury and Stroke Theranostics
- Plasma of COVID-19 Patients Does Not Alter Electrical Resistance of Human Endothelial Blood-Brain Barrier In Vitro
- BV2 Membrane-coated PEGylated-liposomes Delivered hFGF21 to Cortical and Hippocampal Microglia for Alzheimer's Disease Therapy
- Prediction of blood-brain barrier penetrating peptides based on data augmentation with Augur
- Heteroions Radii Matching Produced Intensely Luminescent Bismuth-Ag2S Nanocrystals for through-Skull NIR-II Imaging of Orthotopic Glioma
- Brain asymmetries from mid- to late life and hemispheric brain age
- Identification of Novel, Selective Ataxia-Telangiectasia Mutated Kinase Inhibitors with the Ability to Penetrate the Blood-Brain Barrier: The Discovery of AZD1390
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting
- Inhibition of piezo1 prevents chronic cerebral hypoperfusion-induced cognitive impairment and blood brain barrier disruption
- Author Correction: ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells
- Edaravone Maintains AQP4 Polarity Via OS/MMP9/β-DG Pathway in an Experimental Intracerebral Hemorrhage Mouse Model
- Cell-mediated nanoparticle delivery systems: towards precision nanomedicine
- Real-time monitoring of abnormal mitochondrial viscosity in glioblastoma with a novel mitochondria-targeting fluorescent probe
- Neonatal brain dynamic functional connectivity in term and preterm infants and its association with early childhood neurodevelopment
- Quantifying the Lymphatic Transport of Model Therapeutics from the Brain in Rats
- Author Correction: Using rare genetic mutations to revisit structural brain asymmetry
- Clozapine-laden carbon dots delivered to the brain via an intranasal pathway: Synthesis, characterization, ex vivo, and in vivo studies
- Perinatal exposure to PFOS and sustained high-fat diet promote neurodevelopmental disorders via genomic reprogramming of pathways associated with neuromotor development
- Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- Bystander activated CD8+ T cells mediate neuropathology during viral infection via antigen-independent cytotoxicity
- Occludin and collagen IV degradation mediated by the T9SS effector SspA contributes to blood-brain barrier damage in ducks during Riemerella anatipestifer infection
- Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia
- Increased Expression of Transferrin Receptor 1 in the Brain Cortex of 5xFAD Mouse Model of Alzheimer's Disease Is Associated with Activation of HIF-1 Signaling Pathway
- Stress, pain, anxiety, and depression in endometriosis-Targeting glial activation and inflammation
- Fibrin promotes oxidative stress and neuronal loss in traumatic brain injury via innate immune activation
- A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
- Protein Corona Composition of Gold Nanocatalysts
- Placenta-brain communication in preeclampsia. What we have learnt from preclinical models.
- A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease
- A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease
- A lupin protein hydrolysate protects the central nervous system from oxidative stress in WD-fed ApoE-/- mice
- A lupin protein hydrolysate protects the central nervous system from oxidative stress in WD-fed ApoE-/- mice
- Schizophrenia endothelial cells exhibit higher permeability and altered angiogenesis patterns in patient-derived organoids
- Sex differences in autism-like behavior and dopaminergic neurons in substantia nigra of juvenile mice prenatally exposed to valproate
- Toxicologic Neuropathology of Novel Biotherapeutics
- Toxicologic Neuropathology of Novel Biotherapeutics
- Compromised transcription-mRNA export factor THOC2 causes R-loop accumulation, DNA damage and adverse neurodevelopment
- Compromised transcription-mRNA export factor THOC2 causes R-loop accumulation, DNA damage and adverse neurodevelopment
- The genetic architecture of multimodal human brain age
- Gut microbiome and serum amino acid metabolome alterations in autism spectrum disorder
- Interferon-α receptor antisense oligonucleotides reduce neuroinflammation and neuropathology in a mouse model of cerebral interferonopathy
- The role of the brain renin-angiotensin system in Parkinsons disease
Evidence Blueprint
CD98hc is a target for brain delivery of biotherapeutics
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
CD98hc is a target for brain delivery of biotherapeutics
🌐 365 Days
VR Related Evidence Matrix
- Antibody-mediated inhibition of tissue-type plasminogen activator binding to the low-density lipoprotein receptor-related protein 1 as a potential beneficial modulator for stroke therapy
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia
- ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells
- In vitro study of the blood-brain barrier transport of bioactives from Mediterranean foods
- Blood-brain barrier disruption in dementia: Nano-solutions as new treatment options
- Not open and shut: Complex and prolonged blood-brain barrier responses after stroke
- Proteomic alterations in the brain and blood-brain barrier during brain Aβ accumulation in an APP knock-in mouse model of Alzheimer's disease
- Identification and quantification of (poly)phenol and methylxanthine metabolites in human cerebrospinal fluid: evidence of their ability to cross the BBB
- Borneol-modified PEGylated graphene oxide as a nanocarrier for brain-targeted delivery of ginsenoside Rg1 against depression
- Blood-brain barrier disruption following brain injury: Implications for clinical practice
- Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review
- Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier
- Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR delta activation
- Manufactured tissue-to-tissue barrier chip for modeling the human blood-brain barrier and regulation of cellular trafficking
- Analysis of ischemic stroke-mediated effects on blood-brain barrier properties along the arteriovenous axis assessed by intravital two-photon imaging
- A new insight into the role of pericytes in ischemic stroke
- Hormonal gatekeeping via the blood-brain barrier governs caste-specific behavior in ants
- Alterations of the blood-brain barrier during aging
- Alcohol binge drinking induces downregulation of blood-brain barrier proteins in the rat frontal cortex -but not in the hippocampus- that is not prevented by OEA pretreatment
- C9ORF72 patient-derived endothelial cells drive blood-brain barrier disruption and contribute to neurotoxicity
- Application of diffusion weighted multiple boli ASL to a murine model of human African trypanosomiasis
- Specific nanoprobe design for MRI: Targeting laminin in the blood-brain barrier to follow alteration due to neuroinflammation
- PET imaging of focused-ultrasound enhanced delivery of AAVs into the murine brain
- Ultrasound-mediated blood-brain barrier opening uncovers an intracerebral perivenous fluid network in persons with Alzheimer's disease
- Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases
- CRTC1 is a potential target to delay aging-induced cognitive deficit by protecting the integrity of the blood-brain barrier via inhibiting inflammation
- Effects of a Small-Molecule Perforin Inhibitor in a Mouse Model of CD8 T Cell-Mediated Neuroinflammation
- Engineered Wnt7a ligands rescue blood-brain barrier and cognitive deficits in a COVID-19 mouse model
- Investigating the origin of the 13 C lactate signal in the anesthetized healthy rat brain in vivo after hyperpolarized [1-13 C]pyruvate injection
- Blood-Brain Barrier Integrity Is Perturbed in a Mecp2-Null Mouse Model of Rett Syndrome
- Inflammation-induced TRPV4 channels exacerbate blood-brain barrier dysfunction in multiple sclerosis
- Enhanced in vivo blood brain barrier transcytosis of macromolecular cargo using an engineered pH-sensitive mouse transferrin receptor binding nanobody
- Binary Nano-inhalant Formulation of Icariin Enhances Cognitive Function in Vascular Dementia via BDNF/TrkB Signaling and Anti-inflammatory Effects
- Neural and Onconeural Autoantibodies and Blood-Brain Barrier Disruption Markers in Patients Undergoing Radiotherapy for High-Grade Primary Brain Tumour
- Elimination of senescent cells by treatment with Navitoclax/ABT263 reverses whole brain irradiation-induced blood-brain barrier disruption in the mouse brain
- Gestational Fisetin Exerts Neuroprotection by Regulating Mitochondria-Directed Canonical Wnt Signaling, BBB Integrity, and Apoptosis in Prenatal VPA-Induced Rodent Model of Autism
- Cognitive impairment and the blood-brain barrier in chronic kidney disease: role of the uremic toxins
- Blood-brain barrier breakdown is linked to tau pathology and neuronal injury in a differential manner according to amyloid deposition
- Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders
- Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma
- Estrogen receptor beta in astrocytes modulates cognitive function in mid-age female mice
- Biodistribution of Agmatine to Brain and Spinal Cord Following Systemic Delivery
- APP/PS1 Gene-Environmental Cadmium Interaction Aggravates the Progression of Alzheimer's Disease in Mice via the Blood-Brain Barrier, Amyloid-β, and Inflammation
- Feasibility of measuring blood-brain barrier permeability using ultra-short echo time radial magnetic resonance imaging
- Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii
- Blood-brain barrier breakdown and autoimmune cerebellar ataxia
- Neutrophil Targeting Platform Reduces Neutrophil Extracellular Traps for Improved Traumatic Brain Injury and Stroke Theranostics
- Neonatal immune challenge poses a sex-specific risk for epigenetic microglial reprogramming and behavioral impairment
- Interaction between GPR110 (ADGRF1) and tight junction protein occludin implicated in blood-brain barrier permeability
- Lung infection by Pseudomonas aeruginosa induces neuroinflammation and blood-brain barrier dysfunction in mice
- Blood-Brain Barrier Dysfunction and Exposure to Head Impacts in University Football Players
- Plasma of COVID-19 Patients Does Not Alter Electrical Resistance of Human Endothelial Blood-Brain Barrier In Vitro
- Regional differences in the link between water exchange rate across the blood-brain barrier and cognitive performance in normal aging
- Microfluidic models of the neurovascular unit: a translational view
- Ultrasound-Targeted Microbubble Destruction Increases BBB Permeability and Promotes Stem Cell-Induced Regeneration of Stroke by Downregulating MMP8
- Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells Attenuates Heat Stress-Induced Exacerbation of Neuropathology Following Brain Blast Injury
- Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer's disease
- Brain-to-gut trafficking of alpha-synuclein by CD11c+ cells in a mouse model of Parkinson's disease
- Chronic kidney disease causes blood-brain barrier breakdown via urea-activated matrix metalloproteinase-2 and insolubility of tau protein
- Nano-delivery systems as a promising therapeutic potential for epilepsy: Current status and future perspectives
- BV2 Membrane-coated PEGylated-liposomes Delivered hFGF21 to Cortical and Hippocampal Microglia for Alzheimer's Disease Therapy
- Prediction of blood-brain barrier penetrating peptides based on data augmentation with Augur
- AAV-mediated expression of a new conformational anti-aggregated α-synuclein antibody prolongs survival in a genetic model of α-synucleinopathies